hTERT mediates gastric cancer metastasis partially through the indirect targeting of ITGB1 by microRNA-29a
dc.contributor.author | He, B | |
dc.contributor.author | Xiao, Y-F | |
dc.contributor.author | Tang, B | |
dc.contributor.author | Wu, Y-Y | |
dc.contributor.author | Hu, C-J | |
dc.contributor.author | Xie, R | |
dc.contributor.author | Yang, X | |
dc.contributor.author | Yu, S-T | |
dc.contributor.author | Dong, H | |
dc.contributor.author | Zhao, X-Y | |
dc.contributor.author | Li, J-L | |
dc.contributor.author | Yang, S-M | |
dc.date.accessioned | 2016-08-09T14:38:02Z | |
dc.date.available | 2016-08-09T14:38:02Z | |
dc.date.issued | 2016 | |
dc.identifier.issn | 2045-2322 | |
dc.identifier.issn | 2045-2322 | |
dc.identifier.other | 21955 | |
dc.identifier.uri | http://hdl.handle.net/10026.1/5242 | |
dc.description.abstract |
<jats:title>Abstract</jats:title><jats:p>Human telomerase reverse transcriptase (hTERT) plays a key role in tumor invasion and metastasis, but the mechanism of its involvement in these processes is not clear. The purpose of this study is to investigate the possible molecular mechanism of hTERT in the promotion of gastric cancer (GC) metastasis. We found that the up-regulation of hTERT in gastric cancer cells could inhibit the expression of miR-29a and enhance the expression of Integrin β1 (ITGB1). In addition, the invasive capacity of gastric cancer cells was also highly increased after hTERT overexpression. Our study also found that the restoration of miR-29a suppressed the expression of ITGB1 and inhibited GC cell metastasis both <jats:italic>in vitro</jats:italic> and <jats:italic>in vivo</jats:italic>. Taken together, our results suggested that hTERT may promote GC metastasis through the hTERT-miR-29a-ITGB1 regulatory pathway.</jats:p> | |
dc.format.extent | 21955- | |
dc.format.medium | Electronic | |
dc.language | en | |
dc.language.iso | eng | |
dc.publisher | Springer Science and Business Media LLC | |
dc.subject | Adaptor Proteins, Signal Transducing | |
dc.subject | Aged | |
dc.subject | Animals | |
dc.subject | Base Sequence | |
dc.subject | Cell Line, Tumor | |
dc.subject | Cell Movement | |
dc.subject | Epithelial Cells | |
dc.subject | Female | |
dc.subject | Gene Expression Regulation, Neoplastic | |
dc.subject | Genetic Vectors | |
dc.subject | Humans | |
dc.subject | Injections, Subcutaneous | |
dc.subject | Intracellular Signaling Peptides and Proteins | |
dc.subject | Lentivirus | |
dc.subject | Male | |
dc.subject | Membrane Proteins | |
dc.subject | Mice | |
dc.subject | Mice, Nude | |
dc.subject | MicroRNAs | |
dc.subject | Middle Aged | |
dc.subject | Neoplasm Invasiveness | |
dc.subject | Neoplasm Metastasis | |
dc.subject | Neoplasm Transplantation | |
dc.subject | Osteoblasts | |
dc.subject | Signal Transduction | |
dc.subject | Stomach Neoplasms | |
dc.subject | Survival Analysis | |
dc.subject | Telomerase | |
dc.title | hTERT mediates gastric cancer metastasis partially through the indirect targeting of ITGB1 by microRNA-29a | |
dc.type | journal-article | |
dc.type | Article | |
plymouth.author-url | https://www.ncbi.nlm.nih.gov/pubmed/26903137 | |
plymouth.issue | 1 | |
plymouth.volume | 6 | |
plymouth.publication-status | Published online | |
plymouth.journal | Scientific Reports | |
dc.identifier.doi | 10.1038/srep21955 | |
plymouth.organisational-group | /Plymouth | |
plymouth.organisational-group | /Plymouth/REF 2021 Researchers by UoA | |
plymouth.organisational-group | /Plymouth/REF 2021 Researchers by UoA/UoA01 Clinical Medicine | |
plymouth.organisational-group | /Plymouth/REF 2021 Researchers by UoA/UoA01 Clinical Medicine/UoA01 Clinical Medicine | |
dc.publisher.place | England | |
dcterms.dateAccepted | 2016-02-02 | |
dc.identifier.eissn | 2045-2322 | |
dc.rights.embargoperiod | Not known | |
rioxxterms.versionofrecord | 10.1038/srep21955 | |
rioxxterms.licenseref.uri | http://www.rioxx.net/licenses/all-rights-reserved | |
rioxxterms.licenseref.startdate | 2016-02-23 | |
rioxxterms.type | Journal Article/Review |